← Back
Sight Sciences
SGHT · listed on Nasdaq · worth $533.25 million
$9.68
+2.76% on Nov 4
Two insider buys in the last year, $184.8K in all. None in the last two weeks.
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
35.5M shares
64% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Sight Sciences stock and six insiders sold. Ten of the 31 sales are marked on the filing as planned in advance; all by company executives. The biggest seller was Jeremy B. Hayden, Chief Legal Officer.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
10% owner
Staffan Encrantz
Bought $116K on Dec 16, 2025 — 13,958 shares at $8.31, 1.0% of what they now own.
1 of 2 earlier purchases did better than the S&P 500
Planned sales
Form 144 notices filed for Sight Sciences in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
COO Alison Bauerlein filed to sell 25,260 shares on 2 Oct; sold 25,260 by 2 OctNotice on SEC.gov
CFO James Rodberg filed to sell 7,208 shares on 2 Oct; sold 7,208 by 2 OctNotice on SEC.gov
Brenton Taylor filed to sell 2,988 shares on 2 Oct; sold 2,988 by 2 OctNotice on SEC.gov
All reports
Every insider trade and SEC report we hold for Sight Sciences.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 5SoldBrenton TaylorOct 5 · Traded Oct 2 · EVP, Operations & R&D · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.2,988 @ $8.85$26.5K
Oct 5SoldAlison BauerleinOct 5 · Traded Oct 2 · Chief Operating Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.25,260 @ $8.85$223.6K
Oct 5SoldJames RodbergOct 5 · Traded Oct 2 · Chief Financial Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.7,208 @ $8.85$63.8K
Oct 5SoldDavid BadawiOct 5 · Traded Oct 1 · Chief Technology Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.7,797 @ $9.05$70.6K
Jul 6SoldJeremy B. HaydenJul 6 · Chief Legal Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.12,733 @ $5.51$70.1K
47 more with Pro →Analysts, earnings and news
Analysts' price target
$8.54 average
4 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q1 '26−$0.24 a share−$0.04
Q4 '25−$0.08 a share+$0.06
Q3 '25−$0.16 a share+$0.10
Q2 '25−$0.23 a share+$0.05